Premium
Private equity firms KKR, TPG Capital and Apax Partners are evaluating India's largest cardiac stent maker Sahajanand Medical Technologies (SMT), valuing the company at Rs 3,500-4,000 crore, a media report said. One more global private equity firm and Mumbai-based pharmaceutical firm Alkem Laboratories are also in the fray, The Economic Times reported, citing people familiar with ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.